Biomarker Use in Colorectal Cancer Therapy

被引:29
作者
Kelley, Robin K. [1 ]
Wang, Grace [2 ]
Venook, Alan P.
机构
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Med, San Francisco, CA 94115 USA
[2] UCSF, Ctr Translat & Policy Res Personalized Med, San Francisco, CA USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2011年 / 9卷 / 11期
关键词
Colon cancer; colorectal cancer; biomarker; KRAS; BRAF; microsatellite instability; mismatch repair; REVISED BETHESDA GUIDELINES; DEFECTIVE MISMATCH REPAIR; CIRCULATING TUMOR-CELLS; MICROSATELLITE-INSTABILITY; ADJUVANT CHEMOTHERAPY; COLON-CANCER; LYNCH-SYNDROME; PREDICTIVE BIOMARKERS; MOLECULAR PREDICTORS; THYMIDYLATE SYNTHASE;
D O I
10.6004/jnccn.2011.0105
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Biomarkers reflective of the molecular and genetic heterogeneity in colorectal cancers now guide certain aspects of clinical management and offer great potential for enrichment, stratification, and identification of novel therapeutic targets in drug development. Using case-based examples, this article reviews biomarkers that have an established role in the clinical management of colorectal cancer: mismatch repair protein testing and KRAS and BRAF mutational analysis. A selection of biomarkers undergoing validation for future clinical application is presented, and the dynamic and challenging interface between biomarkers in research and clinical practice is discussed. (JNCCN 2011;9:1293-1303)
引用
收藏
页码:1293 / 1302
页数:10
相关论文
共 71 条
[1]   DNA Methylation Predicts Recurrence From Resected Stage III Proximal Colon Cancer [J].
Ahn, Joong Bae ;
Chung, Woon Bok ;
Maeda, Osamu ;
Shin, Sang Joon ;
Kim, Hyun Soo ;
Chung, Hyun Chul ;
Kim, Nam Kyu ;
Issa, Jean-Pierre J. .
CANCER, 2011, 117 (09) :1847-1854
[2]   Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].
Amado, Rafael G. ;
Wolf, Michael ;
Peeters, Marc ;
Van Cutsem, Eric ;
Siena, Salvatore ;
Freeman, Daniel J. ;
Juan, Todd ;
Sikorski, Robert ;
Suggs, Sid ;
Radinsky, Robert ;
Patterson, Scott D. ;
Chang, David D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634
[3]  
[Anonymous], J CLIN ONCOL S1
[4]  
[Anonymous], ASCO GASTR CANC S JA
[5]  
[Anonymous], NCCN CLIN PRACTICE G
[6]  
[Anonymous], ERB CET MED GUID
[7]  
[Anonymous], J CLIN ONCOL S1
[8]  
[Anonymous], CANCER IN PRESS
[9]  
[Anonymous], HIGHL PRESCR INF VEC
[10]   Predictive and Prognostic Biomarkers for Targeted Therapy in Metastatic Colorectal Cancer [J].
Asghar, Uzma ;
Hawkes, Eliza ;
Cunningham, David .
CLINICAL COLORECTAL CANCER, 2010, 9 (05) :274-281